![]() |
인쇄하기
취소
|
Domestic products of Amgen which will be officially launched have been visualized.
According to the industry concerned on the 12th, the Korean branch of Amgen turned in applications of ‘Kyprolis(carfilzomib),’ a multiple myeloma treatment, and ‘Blincyto(blinatumomab)’, an acute lymphoblastic leukemia treatment, to the Ministry of Food and Drug Safety.
The fields that the two drugs are aiming ...